Virus Risk Mitigation in Viral Vector and Gene Therapy Cell Culture Media

This poster underscores the importance of virus risk mitigation in the production of viral vectors and gene therapies, detailing a three-tiered strategy that evolves with therapeutic advancements. It discusses the role of chemically defined media, virus clearance, and closed aseptic processing in ensuring safety at a commercial scale, and highlights the effectiveness of Virosart^® Media in virus filtration, with an emphasis on the necessity of advanced screening technologies for cell culture media and raw materials.

Key Takeaways

• Learn how a three-tiered viral risk mitigation strategy supports production safety for viral vector and gene therapy.
• See why using chemically defined media, virus clearance steps, and closed aseptic processing is crucial for commercialization.
• Understand what makes advanced screening technologies important for virus risk mitigation in cell culture media and raw materials.